FeetMe
FeetMe is a Paris-based digital health company that develops CE-marked connected smart insoles with embedded pressure sensors and companion software for clinical gait assessment, diabetic foot monitoring, and athletic performance analysis, sold exclusively to healthcare professionals.
- Company typePrivate
- Founded2013
- HeadquartersParis, France
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What FeetMe does
FeetMe is a Paris-based digital health company founded in 2013 that develops connected smart insoles and companion software for clinical and athletic gait and plantar pressure assessment. Its hardware platform comprises flexible insoles embedded with eighty pressure sensors sampling at 100Hz, communicating via Bluetooth to a smartphone app (FeetMe Holter) and to a clinical desktop application (FeetMe Podiatrist) that computes dynamic and static gait metrics including peak pressure maps, center of pressure movement, walking symmetry, Romberg Ratio, and Fourier analysis. FeetMe One is CE-marked as a medical device and ISO 13485 / ISO 9001 certifications underpin the company's regulatory positioning for diabetic foot monitoring, while FeetMe Diagnosis targets clinical use cases such as post-surgery assessment and orthotic design, and FeetMe Sport and FeetMe Mysoles extend the platform into athletic performance and custom orthotic fabrication respectively.
The company operates a B2B sales-led and enterprise-field-sales go-to-market, selling exclusively to healthcare professionals (podiatrists, sports medicine specialists, hospitals) via direct contact and quote-based pricing with multi-year contracts; it does not sell direct to consumers and instead connects end users to equipped clinicians through a "Find a Specialist" program on its website. Revenue is generated through hardware sales of the smart insole product lines and licensing of the FeetMe Podiatrist analysis software, with FeetMe Mysoles adding an orthotic manufacturing productized workflow supported by a co-development partnership with Thuasne. The team is approximately 8 people across hardware, mechanical, software, and data science functions, and the company has raised roughly $19.5M across multiple rounds between 2014 and 2024 from investors including SOSV/HAX, Kurma Partners, LBO France, Idinvest, Partech, Seventure Partners, and BPI France.
FeetMe firmographics
Firmographics- Name
- FeetMe
- Legal name
- FeetMe
- Website
- https://feetme.fr
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- FeetMe is a Paris-based digital health company that develops CE-marked connected smart insoles with embedded pressure sensors and companion software for clinical gait assessment, diabetic foot monitoring, and athletic performance analysis, sold exclusively to healthcare professionals.
- Ownership category
- akta.pro rank
FeetMe industry classification
Industry- Product category
- Medical Wearable Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Footwear Manufacturing (3162)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
- akta.pro primary industry
- Specialty & Orthopedic Footwear Manufacturing (Medical/Diabetic/Custom) (IMAOAIAI)
- akta.pro secondary industries
- Patch Pumps & Wearable Insulin Delivery (HLAHAHAC), Footwear Components & Materials (Uppers, Soles, Laces, Insoles) (CRAAACAK), Performance Footwear (Running, Training, Court) (CRAAAEAI)
Keywords
Where FeetMe is headquartered
LocationHeadquarters
- HQ city
- Paris
- HQ country
- France
- HQ region
- Europe
Offices1 record
Markets served
FeetMe business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales
Revenue model
- Smart insole hardware sales: FeetMe sells connected insole hardware products (FeetMe One, FeetMe Diagnosis, FeetMe Sport) directly to healthcare professionals and medical institutions. Products are medical devices marked CE.
- Software licensing: FeetMe Podiatrist software is part of the solution offering for healthcare professionals to analyze gait and pressure data collected from the smart insoles.
- Custom orthotics (MySoles): FeetMe MySoles system allows podiatrists to design and receive custom orthotic insoles for their patients, creating a product-based revenue stream.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Quote-based pricing for healthcare professionals |
Go-to-market motion2 records
Distribution channels1 record
Marketing channels4 records
FeetMe product offering
Product offeringCore offering
FeetMe manufactures and sells connected smart insoles embedded with 80 pressure sensors sampling at 100Hz, designed for healthcare professionals to perform clinical gait analysis and continuous plantar pressure monitoring. The offering combines the hardware insoles with the FeetMe Holter mobile app for data collection and the FeetMe Podiatrist desktop software for computing dynamic and static gait parameters. Product lines include FeetMe One (CE-marked medical device for diabetic foot monitoring), FeetMe Diagnosis (clinical assessment), FeetMe Sport (athletic performance), and FeetMe Mysoles (custom orthotic design and fabrication).
Product overview
FeetMe offers a platform of connected smart insoles for plantar pressure measurement. The core portfolio consists of FeetMe One (CE-marked medical device for diabetic patient monitoring), FeetMe Diagnosis (clinical-grade connected insole), and FeetMe Sport (sports performance variant). Supporting modules include FeetMe Mysoles (custom orthotic design system for podiatrists), FeetMe Holter (mobile data collection app), and FeetMe Podiatrist (analysis software). All products connect via Bluetooth to smartphones for real-time analytics.
Differentiator
Problem solved
Functional benefit
Brands
- FeetMe One: Medical device connected insole for diabetic patient monitoring, CE marked, designed for daily use with real-time plantar pressure alerts
- FeetMe Diagnosis
- FeetMe Sport
- FeetMe Mysoles
- FeetMe Podiatrist
- FeetMe Holter
Products and services
- FeetMe One CE-marked connected insole medical device embedded with 80 pressure sensors sampling at 100Hz, designed for diabetic patients to monitor plantar pressure in real time and prevent foot ulcers and amputations. Intended for daily wear in any shoe, with instant alerts when a change in plantar pressure is detected.
- FeetMe Diagnosis Smart connected insole that measures reliable plantar pressure data and transmits them wirelessly to a device for clinical assessment by health professionals. Used for post-surgery biomechanical assessment, orthotics design, and drop-foot surgery evaluation in podiatry practices.
- FeetMe Sport Technology adapted from the FeetMe platform to analyze sport technique and sport performance, with development of specific metrics to follow and advise athletes in their daily activity.
- FeetMe Mysoles Design and fabrication system of insoles for podiatrists. MySoles offers all tools allowing the podiatrist to design and receive the custom orthotic insoles their patients need.
- FeetMe Holter Dedicated smartphone application for collecting plantar pressure data anywhere, anytime, with wireless connectivity for data transfer to a computer. Used as part of the FeetMe solution alongside the connected insoles.
- FeetMe Podiatrist Desktop software that computes dynamic parameters including peak pressure maps, pressure-time integral maps, center of pressure movement and variability, the Lateral Medial Force Index, walking symmetry, and temporal gait analysis, plus static analysis metrics such as center of gravity position, velocity and acceleration, confidence ellipse, ANO2X and ANO2Y, Romberg Ratio, and Fourier analysis.
Quantifiable outcome
- Comprehensive foot-care strategy combining education, prevention, multidisciplinary therapeutic management and close monitoring could reduce amputation rate by up to 85%
- +3 more outcomes
Companies that use FeetMe
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
FeetMe technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
FeetMe partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- ThuasnecoreMedical devices and orthotics company. Shown in product imagery alongside FeetMe Diagnosis, suggesting a co-development or distribution partnership for orthotic solutions.
- BearingPointminorManagement and technology consulting firm. Listed as a supporter in FeetMe's logo section.
- France BiotechminorFrench association of health technology companies. Listed as a supporter in FeetMe's logo section.
Scale indicators2 records
Recent moves6 records
Expansion highlights6 records
FeetMe competitors and assessment
Company assessmentDirect peers
- Salfordinsole / Salford Podiatry Lab: Salfordinsole provides podiatry-focused digital insole design and fabrication systems for custom orthotics, including pressure assessment tools. Its offering is highly comparable to FeetMe Mysoles and FeetMe Diagnosis in the podiatry practice workflow for custom orthotic design.
- Tekscan: Tekscan manufactures high-resolution pressure mapping systems including in-shoe sensor insoles used in clinical gait analysis, diabetic foot assessment, and sports research. It is the most established direct competitor to FeetMe's pressure-sensor insole platform, with comparable technology positioning and overlapping customer base in podiatry and biomechanics labs.
- Digitsole: Digitsole, also a French company, makes connected smart insoles for gait analysis, diabetic foot monitoring, and performance. It is a close direct competitor to FeetMe with overlapping target segments (podiatry, diabetic foot, sports) and similar B2B distribution through healthcare professionals.
- Moticon: Moticon produces sensor insoles for sports performance and clinical gait monitoring with wireless data capture. It competes directly with FeetMe Sport and FeetMe Diagnosis in the wireless insole category, particularly in running gait analytics and orthopedic rehabilitation use cases.
- Novel GmbH (novel.de): Novel (novel.de) produces pedar and emed pressure measurement insoles and platforms widely used in clinical gait analysis, diabetic foot care, and sports biomechanics. Its in-shoe pressure systems directly overlap with FeetMe Diagnosis and FeetMe One in both technology and end-user (podiatrists, orthopedic clinics).
- zebris Medical GmbH: zebris Medical offers instrumented treadmill systems and pressure measurement solutions for gait and posture analysis, serving orthopedic and rehabilitation clinics across Europe. It is a direct competitor in clinical gait analysis workflows that FeetMe Diagnosis targets, with overlapping European clinical customer base.
Emerging players
- Sensoria Fitness: Sensoria develops smart insoles and socks with embedded pressure sensors aimed at running, gait, and diabetic foot monitoring. Its consumer and clinical products overlap with both FeetMe Sport and FeetMe One, though Sensoria has historically targeted fitness use cases more than regulated medical indications.
- RunScribe: RunScribe provides wearable gait and running biomechanics analysis tools for athletes and coaches. It overlaps with FeetMe Sport in the athletic-performance segment, though its hardware is attached to shoes rather than embedded in insoles, making it a partial rather than full competitor.
Regional players
- Surestep: Surestep manufactures custom and off-the-shelf medical orthotic insoles primarily for the pediatric and diabetic foot market in North America. It is comparable to FeetMe's Mysoles and FeetMe One product lines in addressing custom orthotic needs for diabetic and at-risk patients, with primary geographic focus in the US rather than Europe.
Others
- Thuasne: Thuasne is a leading European manufacturer of medical devices and orthopedic solutions, including custom orthotics and braces. Although listed as a FeetMe partner, Thuasne is also a potential adjacent competitor/complementor in orthopedic insoles and could choose to develop or distribute competing in-shoe sensor solutions.
Market position
Strengths5 records
Weaknesses3 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
FeetMe social profiles
Digital presenceFeetMe compliance and trust
Trust signalCompliance3 records
FeetMe financial estimates
Financial estimateRevenue estimate
Valuation estimate
FeetMe leadership team
Management profileNumber of profiles
Profiles8 records
FeetMe funding detail
Funding detailFunding overview
Funding rounds8 records
Investors10 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
FeetMe M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about FeetMe
What does FeetMe do?
FeetMe manufactures and sells connected smart insoles embedded with 80 pressure sensors sampling at 100Hz, designed for healthcare professionals to perform clinical gait analysis and continuous plantar pressure monitoring. The offering combines the hardware insoles with the FeetMe Holter mobile app for data collection and the FeetMe Podiatrist desktop software for computing dynamic and static gait parameters. Product lines include FeetMe One (CE-marked medical device for diabetic foot monitoring), FeetMe Diagnosis (clinical assessment), FeetMe Sport (athletic performance), and FeetMe Mysoles (custom orthotic design and fabrication).
Is FeetMe a public or private company?
FeetMe is a private company. It is classified as venture growth investor backed and is currently operating.
When was FeetMe founded?
FeetMe was founded in 2013. It employs 11 to 50 people.
Where is FeetMe based?
FeetMe is headquartered in Paris, France, in the Europe region.
How does FeetMe make money?
Three revenue lines are on record. Smart insole hardware sales are the primary driver. The others are software licensing and custom orthotics (MySoles).
Who are FeetMe's main competitors?
Direct peers on record are Salfordinsole / Salford Podiatry Lab, Tekscan, Digitsole, Moticon, Novel GmbH (novel.de) and zebris Medical GmbH. Emerging players are Sensoria Fitness and RunScribe. Surestep is listed as a regional player. Thuasne is listed as an others.
Does FeetMe have an API?
No public API is recorded for FeetMe.
What industry is FeetMe in?
FeetMe's product category is Medical Wearable Devices. Its primary akta.pro industry code is IMAOAIAI, Specialty & Orthopedic Footwear Manufacturing (Medical/Diabetic/Custom), with a secondary code of HLAHAHAC, Patch Pumps & Wearable Insulin Delivery. Its NAICS code is 334510 and its SIC code is 3845.